Background: The rate-limiting step of the renin-angiotensin system is the enzymatic cleavage of angiotensinogen (AGT) by renin. The aims of the present study were to investigate the association between AGT T704C (M235T) and −217 G→A polymorphisms with the risk of preeclampsia and synergistic effects of both polymorphisms on the susceptibility to preeclampsia. Methods: We studied AGT variants in 170 women with preeclampsia, including 84 women with mild and 86 women with severe forms of preeclampsia, and 100 age and parity matched controls. Results: There was a trend towards increased risk of severe preeclampsia in the presence of −217 AA (odds ratio (OR)=1.5, 95% confidence interval (CI)= 0.38-5.84, p=0.57) and TC+CC genotypes (OR=1.32, 95% CI= 0.67-2.58, p=0.42). However, the interaction of both alleles of −217A and 704C highly increased the risk of severe preeclampsia, by 2.23-fold, although this did not reach statistical significance. The frequency of the CC genotype of the T704C polymorphism in early-onset preeclampsia tended to be higher (35%) compared with that in patients with late-onset preeclampsia (21.7%).
Introduction
Preeclampsia is a common complication of pregnancy, with an incidence rate of 5-7% of all pregnancies. It is a multifactorial disorder with a familial tendency that results from complex interactions between a variety of genetic and environmental factors. 1 Stimulation of the renin-angiotensin-aldosterone system (RAAS) during normal pregnancy results in increasing plasma levels of renin, angiotensinogen (AGT), angiotensin II and aldosterone. 1, 2 Suppression of the RAAS system, increased vascular resistance and the absence of physiologic development of pregnancy hypervolemia have been implicated in the pathogenesis of preeclampsia. 1 The rate-limiting step of the RAAS is the enzymatic cleavage of AGT by renin and conversion of AGT to angiotensin II, which plays a primary role in the regulation of blood pressure. 1 Polymorphisms in the promoter region of AGT are of significance, because they may influence the strength of the AGT promoter and, consequently, the levels of AGT and angiotensin II. A variant at position −217 affects baseline activity of the AGT promoter and is associated with hypertension. 3 The −217A allele has a prevalence of 4% to 42% in different ethnicities. The frequency of −217A is elevated in black hypertensive patients, and the A at position −217 increases binding of the CCAAT box/ enhancer binding protein (C/EBP) transcription factor, as well as the glucocorticoid receptor. 3 The common polymorphism of AGT T704C gene encodes threonine instead of methionine at residue 235 in exon 2 (M235T variant). The presence of 704C allele is associated with increased AGT levels. 4 There are controversial reports related to the role of AGT 704T allele in the pathogenesis of preeclampsia. In some studies association of AGT 704C allele with preeclampsia has been confirmed. 5, 6 However, other studies failed to indicate a role for AGT M235T polymorphism in the pathogenesis of preeclampsia. 4, 7, 8 According to the literature there is only one available study to examine the role of AGT −217 G→A polymorphism in the pathogenesis of preeclampsia. In this study Jenkins et al. 9 indicated an absence of association between AGT −217 G→A polymorphism and increased risk of preeclampsia.
Previously, we reported that angiotensin converting enzyme insertion/deletion (ACE I/D) polymorphism, a key RAAS component, is associated with the risk of preeclampsia in our population. 10 In the present study we investigate the possible influence of two polymorphisms of AGT T704C and −217 G→A, alone or in combination with each other, on susceptibility to preeclampsia.
Materials and methods
The sample consisted of 170 women with preeclampsia, including 84 with mild and 86 with severe preeclampsia, with a mean age of 29.6±6.0 years. Controls were 100 age and parity matched healthy pregnant women (mean age 29.2±6.1 years). The preeclamptic women were selected from patients who were referred to the obstetric clinic of the Imam Reza Hospital of Kermanshah University of Medical Sciences. Those with multiplebirth pregnancy, previous hypertension, diabetes, cardiac and renal diseases were excluded. All studied individuals had Kurdish ethnic background. Early-onset preeclampsia (before 34 weeks of gestation) was diagnosed in 18 women with severe and four women with mild preeclampsia. The criteria for defining preeclampsia were systolic blood pressure equal to or higher than 140 mmHg, diastolic blood pressure equal to or higher than 90 mmHg, presence of proteinuria by 24-h urinary excretion exceeding 300 mg, a urine protein: creatinine ratio of >0.3, and protein equal to or higher than 30 mg/dl in a random urine sample (1+ reaction on a standard urine dipstick). Severe preeclampsia was defined as blood pressure more than 160/110 mmHg, proteinuria >3+, headache, visual disturbances, upper abdominal pain, serum creatinine and transaminase elevation, thrombocytopenia, and fetal growth restriction. 11 Informed written consent was obtained from each individual before participation in the study. The study was approved by the Ethics Committee of Kermanshah University of Medical Sciences and was in accordance with the principles of the Declaration of Helsinki II.
T704C (M235T) genotypes
DNA was extracted from leukocytes using the phenol-chloroform method. 12 Using two primers of 5'-GAT GCG CAC AAG GTC CTG TC-3' and 5'-CAG GGT GCT GTC CAC ACT GGA CCC C-3', 9 a 303 bp fragment in exon 2 of AGT gene was amplified using polymerase chain reaction (PCR). The PCR product was digested with 2U of TthIII I restriction enzyme. The presence of tyrosine (704C allele) created a restriction site recognized by TthIII I, which produces two fragments with 279 bp and 24 bp, while in the presence of methionine (704T allele) only a fragment with 303 bp is observed.
−217 G→A genotypes
For detection of −217 G→A polymorphism in the promoter of AGT, a fragment with 234 bp was amplified using the forward primer of 5'-CTC AGG CTG TCA CAC ACC TA-3' and 5'-GAG AGG AGG GTT ACA TCA CTT G-3'. 13 The conversion of G to A creates a restriction site for Alu 1 restriction enzyme, which produces two fragments with 137 bp and 97 bp.
Statistical analysis
The allelic frequencies were calculated by the chromosome counting method. The significance of differences in genotype and allele frequencies of T704C and −217G→A polymorphisms between patients and controls were calculated using χ 2 test. Odds ratios (OR) were calculated as estimates of relative risk for disease and 95% confidence intervals (CI) were obtained by SPSS logistic regression software (SPSS Inc., Chicago, Illinois, USA). A two-tailed Student's t test was used to compare quantitative data. Statistical significance was assumed at the p<0.05 level. The SPSS statistical software package version 16 was used for the statistical analysis. Table 1 shows the frequency of −217 G→A genotypes and alleles. As depicted in Table 1 , the prevalence of AA and GA+AA genotypes was non-significantly higher (5.8 and 39.5%, respectively) in severe preeclamptic women compared with those in controls (4 and 37%, respectively). Also, the prevalence of −217 A allele tended to be higher in women with severe preeclampsia (22.7%) than in controls (21%). The presence of −217 AA genotype was associated with 1.5-fold increased risk of severe preeclampsia, which did not reach statistical significance ( Table 2) .
Results
We were able to detect T704C (M235T) polymorphism in 149 preeclamptic patients. As depicted in Table  3 , the frequency of TC+CC genotype was higher in severely preeclamptic women (74.3%) compared with controls (69%, p=0.42). Also, as shown in Table 4 , there was a trend towards increased risk of severe preeclampsia in the presence of this genotype (OR=1.32, 95% CI= 0.67-2.58, p=0.42).
The synergistic effect of both alleles of 704C (235T) and −217A on the risk of mild and severe preeclampsia was examined, as shown in Table 5 . We observed that in the presence of both alleles the risk of preeclampsia, especially severe preeclampsia, was highly increased (OR=2.23, p=0. 14) .
The frequency of CC genotype of T704C polymorphism in early-onset preeclampsia was higher (35%) compared with that in patients with late-onset preeclampsia (21.7%), but this did not reach statistical significance.
Discussion
Preeclampsia is a multifactorial disorder of pregnancy; both genetic background and environmental factors are implicated in its pathogenesis. The influence of environmental risk factors, including diet, obesity, stress and other social elements, during pregnancy in the development of preeclampsia in various races might modify the genetic background. 1 Due to the important role of RAAS in blood pressure homeostasis, variants of genes in this system are of interest. The AGT T704C and −217 G→A polymorphisms affect the level of angiotensinogen protein and might be involved in the pathogenesis of preeclampsia. 3, 4 In the present study we observed that the risk of severe preeclampsia non-significantly increased in the presence of each polymorphism of AGT. However, the concomitant presence of both alleles of AGT 704C and −217A resulted in a remarkably, though non-significantly, increased risk of preeclampsia (2.23-fold).
Various frequencies for AGT 704C allele have been reported among different populations: 0.4 to 0.44 in Caucasians, 0.57 to 0.59 among Koreans, 0.71 in Japanese, 0.75 among Chinese and 0.81 in black Americans. 1 The frequency of 704C allele in our healthy pregnant women was around 48%, which is similar to the frequency in Caucasians. AGT polymorphism could be associated with the pathophysiologic mechanisms involved in the pathogenesis of hypertension and preeclampsia, including inflammation, increased oxidative stress, and endothelial dysfunction. 9 The association of AGT T704C polymorphism with the risk of preeclampsia has been investigated in various ethnic groups with inconsistent results. Absence of association between AGT T704C and the risk of preeclampsia has been reported among North Indian women, 4 Black South African women, 8 German women, 7 Caucasian and African American women 9 and Caucasian French Canadian women with preeclampsia. 14 Further, the Genetics of Preeclampsia Consortium (GOPEC) in a large study from England confirmed that the presence of this polymorphism is not associated with increased risk of preeclampsia. 14 Similarly, in our study among preeclamptic women with Kurdish ethnic background AGT T704C polymorphism was not a risk factor for susceptibility to preeclampsia. However, a higher frequency of this polymorphism was obtained in early-onset than in late-onset severe preeclampsia. In contrast, among Japanese preeclamptic women 6 and Caucasian women of Utah 5 the AGT C allele was associated with the risk of preeclampsia. Also, in a recent meta-analysis, association between the TT genotype of the AGT M235T polymorphism with elevated risk of preeclampsia has been reported. Analysis according to ethnicity indicated an increased risk of preeclampsia in Caucasians. 15 Finally, when the genotypes of both mother and newborn were considered in those paired (both mother and newborn) with AGT M235T polymorphism, the risk of preeclampsia significantly increased by 6.67-fold. 16 The study of Jenkins et al. 9 indicated different frequencies of AGT −217 G→A polymorphism among normotensive Caucasians (0.12) and African American women (0.25). In the present study a frequency of 0.21 was obtained for AGT −217 G→A polymorphism in healthy pregnant women. The role of this polymorphism in the pathogenesis of preeclampsia has only been investigated in one study among Caucasian and African American women, which reported lack of association between AGT −217 G→A and increased risk of preeclampsia in both studied races. 9 Also, we did not detect any significant association between this polymorphism and the risk of preeclampsia in our population. However, interestingly, we observed that the concomitant presence of both polymorphisms of AGT −217 G→A and T704C increased the risk of severe preeclampsia 2.23-fold. Since the influence of synergistic effects of these two polymorphisms on the risk of severe preeclampsia has not been examined, more studies in different races with larger sample size may elucidate the association between combined presence of both polymorphisms and the risk of severe preeclampsia.
Discrepancies related to the association between AGT variants and the risk of preeclampsia could be attributed to the differences in sample size, heterogeneity of preeclampsia phenotype, differences in ethnic backgrounds, or genegene and gene-environment interaction.
Briefly, we did not detect any association between AGT −217 G→A or T704C polymorphism and the risk of preeclampsia in a population of pregnant women with Kurdish ethnic background from Western Iran. However, we observed that an interaction between these polymorphisms increased the risk of severe preeclampsia.
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